Brief: Kintara Therapeutics Enters Into Equity Purchase Agreement With Lincoln Park Capital
Aug 3 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS ENTERS INTO EQUITY PURCHASE AGREEMENT
FOR
UP TO $20 MILLION WITH LINCOLN PARK CAPITAL
* KINTARA THERAPEUTICS - TO HAVE RIGHT IN ITS SOLE
DISCRETION TO
SELL TO LPC UP TO $20 MILLION WORTH OF SHARES OF ITS COMMON
STOCK OVER 36-MONTH TERM
* KINTARA THERAPEUTICS INC - CONTROLS TIMING AND AMOUNT OF
ANY
FUTURE SALES OF ITS SHARES OF COMMON STOCK
* KINTARA THERAPEUTICS INC - LPC IS OBLIGATED TO MAKE
PURCHASES IN
ACCORDANCE WITH TERMS OF PURCHASE AGREEMENT
Source text for Eikon: ID:nPnbW7r2Va
Further company coverage: KTRA.O
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.